DIAGENODE

Pharmaceuticals preparations for diagnosis and detection of modified DNA for medical purposes in the field of molecular biology; diagnostic research kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing and diagnostic reagents for medical purposes for diagnosis; reactive products for medical purposes in the field of epigenetics, namely, diagnostic reagent kits comprised of nucleotides, enzymes, monoclonal antibodies, synthetic peptides for the treatment of cancer, and plasmids